Insider · CIK 0002024135
Cole Pinnow
Files at COGT (Cogent Biosciences, Inc.). First filing Jan 15, 2025, latest Jan 15, 2025.
In brief
Cole Pinnow files SEC Form 4 as officer at COGT (Cogent Biosciences, Inc.). Since Jan 15, 2025, Cole Pinnow has reported 1 open-market buy worth $332k and 0 open-market sells worth $0, the latest filed on Jan 15, 2025.
A track record needs three past buys with six months of prices behind them; Cole Pinnow has 0, so none is measured yet.
The newest scored trade: bought $332k of COGT on Jan 14, 2025, filed Jan 15, 2025, scored 40 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
COGT: Cogent Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | COGTbuy Cogent Biosciences, Inc. | $332k 43,750 shares | +2085% | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | AGrant or award Common Stock | +50,000 | $0.00 | $0 | 97,450 | Dec 19, 2025 |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | AGrant or award Common Stock | +214,000 | $0.00 | $0 | 311,450 | Dec 19, 2025 |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | FTax withholding Common Stock | -94,800 | $39.45 | $3.7M | 216,650 | Dec 19, 2025 |
| Dec 17, 2025 | COGT Cogent Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +65,000 | $0.00 | $0 | 65,000 | Dec 19, 2025 |
| Jan 23, 2025 | COGT Cogent Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +240,000 | $0.00 | $0 | 240,000 | Jan 27, 2025 |
| Jan 14, 2025 | COGT Cogent Biosciences, Inc. | POpen-market purchase Common Stock | +43,750 | $7.60 | $332k | 45,848 | Jan 15, 2025 |
Questions about Cole Pinnow
Answered from the filings on this page, as of the latest one.
Is Cole Pinnow buying or selling?
Not in the last 12 months. Cole Pinnow's latest open-market trade on SEC Form 4 was bought $332k of COGT on Jan 14, 2025.
How did Cole Pinnow's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Cole Pinnow has 0.
Where does Cole Pinnow file Form 4?
Cole Pinnow has filed Form 4 at COGT (Cogent Biosciences, Inc.) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.